Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1β, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis

Current Eye Research

Volumn 20, Issue 3, 2000, Pages 211-214

  El Shabrawi, Yosuf ^a   Christen, William G ^a   Foster, C Stephen ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Human; Interleukin 1 receptor antagonists; Interleukin 12; Interleukin 1 ; Matrix metalloproteinases; Proinflammatory cytokines; Uveitis

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 1BETA;

AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REMISSION; UVEITIS; ZYMOGRAPHY;

EID: 0034128106     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/0271-3683(200003)2031-9FT211     Document Type: Article

References (12)

1. Woessner J F Jr. The family of matrix metalloproteinases. Ann N Y Acad Sci. 1994;732:11-21.
2. Goetzl E J, Banda M J, Leppert D. Matrix metalloproteinases in immunity. J Immunol. 1996;156:1-4.
3. Gearing A J, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood L M, Wooley K. Processing of tumor necrosis factor-alpha precursor by metalloproteinases. Nature. 1994; 370:555-557.
4. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. Human mast cell chymase and leukocyte elastase latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem. 1995;270:4689-96.
5. Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA, McElroy A, Menius JA, Jeffreys JJ, Clark RL, McGeeham GM, Connoly KM. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med. 1995;182:449-57.
6. Di Girolamo N, Lloyd A, McCluskey PJ, Filipec M, Wakefield D. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol. 1997;150: 653-66.
7. Riley GP, Harrall RL, Watson PG, Cawston TE, Hazleman BL. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye. 1995; 9:703-18.
8. Hasan M, Najjam S, Gordon MY, Gibbs RV, Rider CC. IL-12 is a heparin binding cytokine. J Immunol. 1999; 162:1064-1070.
9. El-Shabrawi Y, Livir-Rallatos C, Christen W, Foster C S. High Levels of IL-12 in the Aqueous Humor and Vitreous of Uveitis Patients. Ophthalmology. 1998;105: 1659-1663.
10. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234-5.
11. Matsubara M, Zieske JD, Fini ME. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci. 1991;32:3221-37.
12. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997;38:2772-2780.